Fermentas Ltd. is a R&D and manufacturing company, which develop and produce products for genetic engineering, molecular biology, genomic research and other biotechnological investigations (over 400 items). More than 99 % of the products are exported. Expansion of efforts to the field of molecular diagnostics is taking place at the present time. Big scale production of kits for molecular diagnostics is planned.
The enterprise of biotechnological pharmacy Sicor Biotech Ltd. in Lithuania is producing recombinant proteins for medical use (interferon alpha-2b, human growth hormone, granulocyte colonies stimulating factor, erythropoietin). It is the only factory of such a profile in Eastern and Central Europe. Sicor Biotech Ltd. is a member of TEVA group (TEVA Pharmaceutical Industries Ltd., Israel). It has strong and very well equipped research centre, developing technologies for production of recombinant proteins.
The success of Lithuanian Biotech is underscored by the fact that the Institute of Biotechnology in Vilnius has attracted back to Lithuania seventeen (17) scientists who have spent over 3 years abroad. They have now returned to carry out their research in Lithuania bringing with them experience, knowledge and funds.
The Lithuanian government has increased funding of biotech research in the last five years and established new programs such as the Industrial Biotechnology Program. Very appropriate, this year's ScanBalt Forum takes place in Vilnius 24-26 September, organized by the Institute of Biotechnology and the Lithuanian Association of Biotechnology and in parallel with the annual ScanBalt Biomaterial Days. Read more at http://www.scanbalt.org/forum2008
The responsible organizer of ScanBalt Forum 2008, dr. Daumantas Matulis, the head of Laboratory of Biothermodynamics and Drug Design, Institute of Biotechnology, says: "The growing importance of life sciences and biotechnology in Lithuania is being recognized with ScanBalt Forum 2008 to take place in Vilnius. This is a chance to promote Lithuania as an attractive place to work, live and invest. We intend to further strengthen our position as a strong player within life sciences and biotechnology in the Baltic Sea Region - also called ScanBalt BioRegion".
For further information contact Daumantas Matulis at: +370 650 06560 or firstname.lastname@example.org
Read more at http://www.ibt.ltAbout ScanBalt BioRegion and ScanBalt:
Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University
How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy